A Multicenter, Two-Part, Phase 1B Clinical Study Of CMP-001 In Combination With Atezolizumab With And Without Radiation Therapy In Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)

Trial Profile

A Multicenter, Two-Part, Phase 1B Clinical Study Of CMP-001 In Combination With Atezolizumab With And Without Radiation Therapy In Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Jun 2018

At a glance

  • Drugs Atezolizumab (Primary) ; CMP 001 (Primary) ; CMP 001 (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Sponsors Checkmate Pharmaceuticals
  • Most Recent Events

    • 24 Apr 2018 According to the Checkmate Pharmaceuticals media release, company has initiated the treatment in this trial.
    • 20 Apr 2018 Status changed from not yet recruiting to recruiting.
    • 22 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top